Sanofi Genzyme is one of the most important companies in the world in the field of red biotech, at the forefront in the development of innovative therapies for patients with rare and debilitating diseases. Founded in 1981 in Boston (Massachusetts, USA) as a small biotech startup, in 2011 it became part of the Sanofi Group, of which today is the division specialized in rare diseases, multiple sclerosis, oncology and immunology. In Italy it has been present since 1993.

---